SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Adaptimmune Projects Sarcoma Franchise to Deliver US Peak Year Sales up to $400 Million - Presentation at JP Morgan Healthcare Conference
January 4, 2024
 · 
3 min read
InFlectis BioScience Awarded $943,000 Grant from the ALS Association to Advance Ongoing ALS Clinical Trial with the Support of IRCCS Carlo Besta Neurological Institute
January 3, 2024
 · 
2 min read
Hemostemix Clarifies its October 3, 2023 News Release
January 2, 2024
 · 
5 min read
Cloud DX Announces Closing of $1,942,000 Private Placement of Convertible Debenture Units, Amendments to Existing Secured Convertible Securities, and Equity Incentive Grants
January 2, 2024
 · 
9 min read
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement
January 2, 2024
 · 
4 min read
Biosenta Closes Private Placement Financing - Jan 2,2024
January 2, 2024
 · 
3 min read
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement
January 2, 2024
 · 
4 min read
Naturevan Fulfills $103K P.O. and Receives Full Payment
December 21, 2023
 · 
3 min read
Policy
Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS
December 20, 2023
 · 
7 min read
Business
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
December 19, 2023
 · 
5 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us